Full-Life Technologies raised US$150M in financing, led by Vivo Capital, including US$110M in Series D and US$40M in debt. The funds aim to expand operations and R&D efforts.
Amount Raised
$110 Million
Round Type
Series D
ShanghaiBiotechnologyCommunity And LifestyleScience And EngineeringInvestors
Description
Full-Life Technologies, a Suzhou, China-based radiotherapeutics company, raised US$150M in financing. The round consisted of approximately US$110M in Series D equity and US$40M in debt financing. Led by Vivo Capital, the investors included SK Biopharmaceuticals and others. The company intends to use the funds to expand operations and its R&D efforts.
Quick answer
Full Life Technologies raised $110 Million in a Series D round, dated May 19, 2026. Investors: Hong Shan, Tsg Capital, Sky9 Capital, Sk Biopharmaceuticals Co., Ltd., Chengwei Capital, Junson Capital, Yunion and Plaisance. Full Life Technologies is based in Shanghai, Shanghai, China.
- How much did Full Life Technologies raise?
- Full Life Technologies raised $110 Million in a Series D round on May 19, 2026.
- Who invested in Full Life Technologies?
- Hong Shan, Tsg Capital, Sky9 Capital, Sk Biopharmaceuticals Co., Ltd., Chengwei Capital, Junson Capital, Yunion and Plaisance are named as investors in this round.
- What does Full Life Technologies do?
- Full-Life Technologies Limited ("Full-Life") is a fully integrated global radiotherapeutics company headquartered in Shanghai with operations in Europe.
- Where is Full Life Technologies based and how big is it?
- Full Life Technologies is based in Shanghai, Shanghai, China. Fundz records about 60 employees.
- Who are the decision-makers at Full Life Technologies?
- Fundz holds 1 contact at Full Life Technologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Community And Lifestyle and Science And Engineering around the same time
Companies in the same sectors as Full Life Technologies that raised within 45 days of this round, from Fundz verified event records.
- Leyden Labs raised $40M (Funding Round) on June 25, 2026.
- RedHill Biopharma Ltd raised $6M (Post-IPO Equity) on June 18, 2026.
- OliX Pharmaceuticals raised $89M (Post-IPO Equity) on June 4, 2026.
- Advanced NanoTherapies raised $31M (Series B) on June 2, 2026.
- Psilera raised $8.8M (Seed) on May 28, 2026.
- Degron Therapeutics raised $40M (Series A) on May 14, 2026.
Who to call at Full Life Technologies, and when
A new round usually means Full Life Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Full Life Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Full Life Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Full Life Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Full Life Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Full Life Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.